M MOMELOTINIB (is an active metabolite) | MOMELOTINIB | ATC MOMELOTINIB
ANTINEOPLASTIC TREATMENT OF MYELOFIBROSIS JANUS KINASE 1 AND 2 (JAK1/JAK2) INHIBITOR AND AND MUTANT JAK2V617F | - | HT 6 HOUR | JANUS KINASE 1 AND 2 (JAK1/JAK2) | - more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |